REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Contains Seven Members Including Nitrogen, Carbon And Chalcogen > Polycyclo Ring System Which Contains The Seven-membered Hetero Ring As One Of The Cyclos > Tricyclo Ring System Having The Seven-mmbered Hetero Ring As One Of The Cyclos > Nitrogen Bonded Directly To Ring Carbon Of The Seven-membered Hetero Ring Nitrogen Bonded Directly To Ring Carbon Of The Seven-membered Hetero RingNitrogen Bonded Directly To Ring Carbon Of The Seven-membered Hetero Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/30/06 - 20060270656 - Substituted piperazines of azepines, oxazepines and thiazepines Also described are the use of the compounds of formula (I) as antagonists of the dopamine D2 receptor and as agents for the treatment of psychosis and bipolar disorders, and pharmaceutical formulations of the compounds of formula (I). ... 11/16/06 - 20060258639 - Therapeutic combinations for the treatment or prevention of psychotic disorders Therapeutic combinations useful in the treatment or prevention of psychotic disorders, to pharmaceutical compositions containing said combinations, and to their use in the treatment or prophylaxis of psychotic disorders are provided. ... 11/09/06 - 20060252744 - Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents Disclosed herein is the use of N-desmethylclozapine (NDMC) and related compounds to treat a variety of neuropsychiatric diseases including psychosis. It is shown that NDMC and related compounds are agonists or partial agonists at D2 and D3 dopamine receptors and thus may be effective as a dopamine stabilizing agent, allowing ... 11/09/06 - 20060252743 - Method of treating sleep disorders or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent. ... 10/12/06 - 20060229292 - Method of treating childhood disorders or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent. ... 09/07/06 - 20060199798 - Amino bustituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuorpsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes. ... 08/31/06 - 20060194784 - Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuorpsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes. ... 08/24/06 - 20060189594 - Procedure for preparing a pharmaceutically active compound (Graphic) ... 07/27/06 - 20060166965 - Atypical antipsychotic agents having low affinity for the d2 receptor The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia). ... 05/04/06 - 20060094705 - Quetiapine analogs and methods of use thereof The invention relates to novel compounds and methods of using them for modulating sleep. ... 03/23/06 - 20060063755 - Loxapine analogs and methods of use thereof The invention relates to novel compounds and methods of using them for modulating sleep. ... 03/23/06 - 20060063754 - Methods of treating a sleep disorder The invention relates to methods of modulating sleep. ... 10/13/05 - 20050227961 - Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome as defined herein are administered for the treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome. ... 10/06/05 - 20050222121 - Atypical antipsychotic agents having low affinity for the d2 receptor The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia). ... 09/01/05 - 20050192268 - Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuorpsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes. ... 08/04/05 - 20050171088 - Treatment of psychoses with dibenzothiazepine antipsychotic The present invention provides methods for treating depression symptoms associated with bipolar disorder. ... ### FreshPatents.com Support |